National Health Investors (NYSE:NHI) Posts Earnings Results, Beats Estimates By $0.35 EPS

Posted by Geri Gentry on Aug 11th, 2026

National Health Investors (NYSE:NHI – Get Free Report) issued its quarterly earnings data on Monday. The real estate investment trust reported $1.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.84 by $0.35, Zacks reports. The business had revenue of $121.32 million for the quarter, compared to the consensus estimate of $72.12 million. National Health Investors had a return on equity of 9.82% and a net margin of 36.86%.The business’s revenue was up 1.6% on a year-over-year basis. During the same period in the prior year, the business earned $1.22 earnings per share. National Health Investors updated its FY 2026 guidance to 4.740-4.790 EPS.

National Health Investors Trading Down 1.4%

NYSE NHI opened at $74.23 on Tuesday. National Health Investors has a 12 month low of $67.94 and a 12 month high of $91.38. The company has a 50-day moving average of $75.18 and a 200-day moving average of $79.56. The company has a debt-to-equity ratio of 0.83, a current ratio of 8.20 and a quick ratio of 8.20. The company has a market cap of $3.60 billion, a P/E ratio of 23.95, a P/E/G ratio of 3.38 and a beta of 0.51.

National Health Investors Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 6th. Shareholders of record on Wednesday, September 30th will be issued a $0.92 dividend. The ex-dividend date is Wednesday, September 30th. This represents a $3.68 annualized dividend and a yield of 5.0%. National Health Investors’s payout ratio is 118.71%.

Key Stories Impacting National Health Investors

Here are the key news stories impacting National Health Investors this week:

Positive Sentiment: NHI declared a quarterly dividend of $0.92 per share, payable November 6 to shareholders of record on September 30. The dividend implies annualized payments of $3.68 and an approximate 5.0% yield, supporting the stock’s income appeal. National Health Investors dividend announcement
Positive Sentiment: Second-quarter revenue reached $121.32 million, well above the $72.12 million analyst consensus and 1.6% higher year over year. Reported EPS of $1.19 also exceeded the $0.84 consensus estimate by $0.35, while net margin was 36.86%. NHI Announces Second Quarter 2026 Results
Neutral Sentiment: The REIT issued an investor update and supplemental second-quarter portfolio information, giving investors additional detail on its healthcare real estate holdings and operating performance. NHI Issues Investor Update
Negative Sentiment: Quarterly FFO, a key REIT performance measure, was $1.19 per share, below the $1.26 consensus estimate and down from $1.22 a year earlier. This miss is more relevant to REIT investors than the reported EPS beat. National Health Investors Q2 FFO Lag Estimates
Negative Sentiment: NHI set fiscal 2026 EPS guidance at $4.74-$4.79, below the $4.87 analyst consensus. The lowered outlook may outweigh the quarterly headline beat and limit near-term investor enthusiasm.

Analyst Ratings Changes

A number of research firms recently commented on NHI. Weiss Ratings cut National Health Investors from a “buy (b)” rating to a “buy (b-)” rating in a research report on Friday, June 12th. Zacks Research cut shares of National Health Investors from a “hold” rating to a “strong sell” rating in a research note on Thursday, June 25th. BMO Capital Markets decreased their price target on shares of National Health Investors from $90.00 to $80.00 and set an “outperform” rating on the stock in a research note on Monday, June 15th. Cantor Fitzgerald reiterated an “overweight” rating and set a $94.00 price target on shares of National Health Investors in a report on Wednesday, April 22nd. Finally, Truist Financial cut their price objective on shares of National Health Investors from $89.00 to $81.00 and set a “buy” rating for the company in a research report on Friday, June 12th. Five analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $83.86.

Read Our Latest Stock Analysis on National Health Investors

Insider Buying and Selling

In related news, Director Robert A. Mccabe, Jr. bought 890 shares of the stock in a transaction that occurred on Monday, June 15th. The stock was purchased at an average cost of $71.65 per share, for a total transaction of $63,768.50. Following the completion of the acquisition, the director owned 44,159 shares in the company, valued at $3,163,992.35. This trade represents a 2.06% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO D. Eric Mendelsohn purchased 1,500 shares of the company’s stock in a transaction that occurred on Friday, June 5th. The shares were bought at an average cost of $68.84 per share, with a total value of $103,260.00. Following the transaction, the chief executive officer directly owned 133,316 shares of the company’s stock, valued at $9,177,473.44. The trade was a 1.14% increase in their position. The disclosure for this purchase is available in the SEC filing. 2.70% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in NHI. Smartleaf Asset Management LLC increased its holdings in National Health Investors by 35.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 1,630 shares of the real estate investment trust’s stock valued at $126,000 after purchasing an additional 424 shares in the last quarter. Ieq Capital LLC acquired a new stake in shares of National Health Investors in the fourth quarter valued at about $240,000. Orion Porfolio Solutions LLC purchased a new stake in shares of National Health Investors during the 4th quarter valued at about $212,000. Cibc World Markets Corp acquired a new position in National Health Investors during the 4th quarter worth approximately $238,000. Finally, Renaissance Group LLC boosted its holdings in National Health Investors by 3.8% in the 4th quarter. Renaissance Group LLC now owns 3,206 shares of the real estate investment trust’s stock worth $245,000 after acquiring an additional 117 shares during the period. 62.51% of the stock is owned by hedge funds and other institutional investors.

About National Health Investors

(Get Free Report)

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.